Gilmore Neil O'Neill

Insider Reports History

Entity
Individual
Location
215 First Street, Cambridge, Massachusetts
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Gilmore Neil O'Neill
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gilmore Neil O'Neill:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Editas Medicine, Inc. CEO, Director Common Stock 315,279 $1.73 M $5.50 Jun 4, 2024 Direct
Editas Medicine, Inc. CEO, Director Stock Option (right to buy) 392,100 Mar 2, 2024 Direct
Aptinyx Inc. Director Stock Option (Right to Buy) 40,000 May 26, 2022 Direct
Unity Biotechnology, Inc. Director Stock Option (Right to Buy) 10,000 Jun 21, 2024 Direct

Insider Reports Filed by Gilmore Neil O'Neill

Symbol Company Period Transactions Value $ Form Type Date Filed Role
UBX Unity Biotechnology, Inc. Jun 21, 2024 1 0 4 Jun 21, 2024 Director
EDIT Editas Medicine, Inc. Jun 4, 2024 1 -66,997 4 Jun 6, 2024 CEO, Director
EDIT Editas Medicine, Inc. Mar 2, 2024 5 -732,884 4 Mar 5, 2024 CEO, Director
UBX Unity Biotechnology, Inc. Jun 23, 2023 1 0 4 Jun 26, 2023 Director
EDIT Editas Medicine, Inc. Jun 5, 2023 1 -61,638 4 Jun 7, 2023 CEO, Director
EDIT Editas Medicine, Inc. Mar 2, 2023 2 0 4 Mar 6, 2023 CEO, Director
UBX Unity Biotechnology, Inc. Jun 24, 2022 1 0 4 Jun 27, 2022 Director
EDIT Editas Medicine, Inc. Jun 2, 2022 2 0 4 Jun 6, 2022 CEO, Director
EDIT Editas Medicine, Inc. Jun 1, 2022 0 0 3 Jun 6, 2022 CEO, Director
APTX Aptinyx Inc. May 26, 2022 1 0 4 May 31, 2022 Director
APTX Aptinyx Inc. Oct 19, 2021 1 0 4 Oct 22, 2021 Director
APTX Aptinyx Inc. Oct 19, 2021 0 0 3 Oct 22, 2021 Director
UBX Unity Biotechnology, Inc. Jun 24, 2021 1 0 4 Jun 28, 2021 Director